Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Shire has opened its more-than-$1-billion plasma manufacturing plant near Covington, Georgia. The more than one-million-square-foot facility will add approximately 30% capacity to Shire’s internal plasma manufacturing network once fully...

As part of the US Food and Drug Administration’s (FDA) efforts to promote drug competition and patient access, the agency has issued two draft guidances to advance the development of complex generic drugs. Complex generics are drugs that, by nature...

In keeping with a previously announced decision to divest its prescription (Rx) drug business and focus on consumer healthcare, Perrigo has appointed Murray S. Kessler, formerly Chief Executive Officer (CEO) of the Lorillard Tobacco Company, as...

GlaxoSmithKline (GSK) is closing part of its cephalosporins antibiotics manufacturing plant in Ulverston, England and planning staff reductions of approximately 200 employees. This follows a strategic review from which GSK decided to keep its...

Janssen Pharmaceuticals, one of the pharmaceutical companies of Johnson & Johnson, has formed a license and collaboration deal with Arrowhead Pharmaceuticals, a Pasadena, California-based biotechnology company, to develop and commercialize...

GlaxoSmithKline (GSK) has signed a three-year clinical manufacturing agreement with Hitachi Chemical Advanced Therapeutics Solutions (HCATS), an Allendale, New Jersey-based contract development and manufacturing organization. Under the agreement,...

Novo Nordisk is planning staff reductions of approximately 250 employees in the US as part of a reorganization resulting from an assessment of resource needs against its business priorities. Last month (September 2018), the company announced staff...